Literature DB >> 7624347

Inactivation of simian immunodeficiency virus by hydrostatic pressure.

E Jurkiewicz1, M Villas-Boas, J L Silva, G Weber, G Hunsmann, R M Clegg.   

Abstract

The inactivation of the simian immunodeficiency viruses SIVmac251 and SIVagm by pressures of 150 and 250 MPa was determined. The extent of inactivation depended on the time that the virus was subjected to compression as well as the level of the pressure and at 150 Mpa reached 5 log10 dilution units after approximately 10 hr. The inactivations, which were uniformly carried out at room temperature, were independent of the concentration of the virus. Possible applications of pressure inactivation for molecular biological and clinical use are discussed.

Entities:  

Mesh:

Year:  1995        PMID: 7624347      PMCID: PMC41445          DOI: 10.1073/pnas.92.15.6935

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  11 in total

1.  Effects of hydrostatic pressure on a membrane-enveloped virus: high immunogenicity of the pressure-inactivated virus.

Authors:  J L Silva; P Luan; M Glaser; E W Voss; G Weber
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  Long-term persistent infection of macaque monkeys with the simian immunodeficiency virus.

Authors:  M D Daniel; N L Letvin; P K Sehgal; G Hunsmann; D K Schmidt; N W King; R C Desrosiers
Journal:  J Gen Virol       Date:  1987-12       Impact factor: 3.891

3.  Reversible pressure dissociation of R17 bacteriophage. The physical individuality of virus particles.

Authors:  A T Da Poian; A C Oliveira; L P Gaspar; J L Silva; G Weber
Journal:  J Mol Biol       Date:  1993-06-20       Impact factor: 5.469

Review 4.  The effect of high pressure upon proteins and other biomolecules.

Authors:  G Weber; H G Drickamer
Journal:  Q Rev Biophys       Date:  1983-02       Impact factor: 5.318

Review 5.  High pressure effects on proteins and other biomolecules.

Authors:  K Heremans
Journal:  Annu Rev Biophys Bioeng       Date:  1982

6.  Structural comparison of the external glycoproteins of human and simian immunodeficiency virus.

Authors:  W Lüke; C Fendrich; D Schreiner; R Sprenger; J Rietschel; G Hunsmann
Journal:  Intervirology       Date:  1991       Impact factor: 1.763

7.  Serological and structural comparison of immunodeficiency viruses from man, African green monkey, rhesus monkey and sooty mangabey.

Authors:  E Jurkiewicz; G Hunsmann; M Hayami; Y Ohta; H Schmitz; J Schneider
Journal:  Z Naturforsch C J Biosci       Date:  1988 May-Jun

8.  Experimental infection of rhesus monkeys with SIV isolated from African green monkeys.

Authors:  O Herchenröder; C Stahl-Hennig; W Lüke; J Schneider; G Schulze; H Hartmann; H Schmidt; K Tenner-Racz; P Racz; M Hayami
Journal:  Intervirology       Date:  1989       Impact factor: 1.763

9.  Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III.

Authors:  N L Letvin; M D Daniel; P K Sehgal; R C Desrosiers; R D Hunt; L M Waldron; J J MacKey; D K Schmidt; L V Chalifoux; N W King
Journal:  Science       Date:  1985-10-04       Impact factor: 47.728

10.  Isolation of T-cell tropic HTLV-III-like retrovirus from macaques.

Authors:  M D Daniel; N L Letvin; N W King; M Kannagi; P K Sehgal; R D Hunt; P J Kanki; M Essex; R C Desrosiers
Journal:  Science       Date:  1985-06-07       Impact factor: 47.728

View more
  8 in total

1.  Concentration dependence of the subunit association of oligomers and viruses and the modification of the latter by urea binding.

Authors:  G Weber; A T Da Poian; J L Silva
Journal:  Biophys J       Date:  1996-01       Impact factor: 4.033

2.  Inactivation of Viruses and Bacteriophages as Models for Swine Hepatitis E Virus in Food Matrices.

Authors:  Eva Emmoth; Jordi Rovira; Andreja Rajkovic; Elena Corcuera; Diego Wilches Pérez; Irene Dergel; Jakob R Ottoson; Frederik Widén
Journal:  Food Environ Virol       Date:  2016-10-25       Impact factor: 2.778

3.  Low temperature and pressure stability of picornaviruses: implications for virus uncoating.

Authors:  A C Oliveira; D Ishimaru; R B Gonçalves; T J Smith; P Mason; D Sá-Carvalho; J L Silva
Journal:  Biophys J       Date:  1999-03       Impact factor: 4.033

4.  High-Pressure Biotechnology in Medicine and Pharmaceutical Science.

Authors:  Patrick Masson; Carole Tonello; Claude Balny
Journal:  J Biomed Biotechnol       Date:  2001

5.  Inactivation of avian influenza viruses by hydrostatic pressure as a potential vaccine development approach.

Authors:  Shana Priscila Coutinho Barroso; Ana Clara Vicente Dos Santos; Patrícia Souza Dos Santos; José Nelson Dos Santos Silva Couceiro; Davis Fernandes Ferreira; Dirlei Nico; Alexandre Morrot; Jerson Lima Silva; Andrea Cheble de Oliveira
Journal:  Access Microbiol       Date:  2021-04-13

6.  Intranasal Immunization with Pressure Inactivated Avian Influenza Elicits Cellular and Humoral Responses in Mice.

Authors:  Shana P C Barroso; Dirlei Nico; Danielle Nascimento; Ana Clara V Santos; José Nelson S S Couceiro; Fernando A Bozza; Ana M A Ferreira; Davis F Ferreira; Clarisa B Palatnik-de-Sousa; Thiago Moreno L Souza; Andre M O Gomes; Jerson L Silva; Andréa C Oliveira
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

7.  Potency under pressure: the impact of hydrostatic pressure on antigenic properties of influenza virus hemagglutinin.

Authors:  Schafer L Eichelberger; Ishrat Sultana; Jin Gao; Melkamu Getie-Kebtie; Michail Alterman; Maryna C Eichelberger
Journal:  Influenza Other Respir Viruses       Date:  2013-03-17       Impact factor: 4.380

8.  Full inactivation of human influenza virus by high hydrostatic pressure preserves virus structure and membrane fusion while conferring protection to mice against infection.

Authors:  Carlos H Dumard; Shana P C Barroso; Guilherme A P de Oliveira; Carlos A M Carvalho; Andre M O Gomes; José Nelson S S Couceiro; Davis F Ferreira; Dirlei Nico; Andrea C Oliveira; Jerson L Silva; Patrícia S Santos
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.